"Buttoned Device" Trials no rupture of aneurysmal wall and no migration, leakage or damage (rupture of Dacron cylinder or fracture of wire frame) of graft in all dogs. These grafts remained patent and pressure gradient (PG) was 14 mmHg except one (PG = 60 mmHgl. This was killed and examined by autopsy. The graft was well covered by thin, translucent neointima and effectively recreated the new aortic lumen, completely closing the entry.
A feasibility study was conducted for the transcatheter occlusion of large ostium secundum atrial septal defects (AS Os) using the centering buttoned device (CBO). The CBO is a modification of the buttoned device, in which a centering counter-occluder (COC) is sutured at the central 40% portion of the occluder (OCC); when the centering COC is stretched is forming a balloon shaped structure, pulling the OCC over the center of the ASO; subsequently the COC is buttoned with the OCC, forming a double 8 disk on the right side of the atrial septum. Occlusion was performed in 10 patients 6-56 years old (median 22). All had been rejected for occlusion by the regular buttoned device, either because of large defect size, or inadequate septal rim. The defect size varied between 23-31 mm (median 27) and the device size between 45-60 mm (median 50). All devices were introduced through 11 F long sheaths. All patients remained stable. Seven had immediate effective occlusions and three had residual shunts. Follow·up ranged between 2-6 months. Unbuttoning without embolization was experienced in the second case; despite the trivial residual shunt, the patient developed severe hemolysis and was operated 2 weeks after implantation. The other patients are doing well. Control:
Conclusions
Thrombus formation at sites of vascular injury provides cytokines, growth factors, and biodegradable matrix for cellular migration, proliferation, and matrix synthesis. We hypothesized that potent limitation ofthrombus deposition following coronary arterial injury would significantly attenuate restenotic neointimal formation. Following oversized metallic coil implantation, 26 domestic pigs received either recombinant PEG Hirudin, (7 animals, 1 mg!kg IV bolus, 0.1 mg!kglhr IV for 5 days) with a goal of keeping the ACT at 200 seconds, or placebo (12 animals). Survival until euthanasia was 28 ± 2 days.
Linear regression models were constructed for planimetered mean neointimal (NI) thickness vs. mean vascular injury score (INJ).
The neointima vs. injury regression equations for each group showed statistically significant differences in intercept, but not slope:
lumenal patency which appears to be associated with chronic geometric remodeling despite concurrent intimal proliferation. Treatment of traumatized coronary arteries with CB may be useful in diminishing restenosis in patients undergoing PTCA. The predominant role of geometric remodeling in restenosis after percutaneous coronary angioplasty (PTCA) has recently been described. In this study, Cytochalasin B (CB), a compound which reversibly blocks actin polymerization and thereby inhibits smooth muscle contraction and geometric remodeling, was tested for its abilityto inhibit restenosis after balloon trauma in a swine coronary model. The left circumflex artery was traumatized with a torquable embolectomy catheter and treated with either saline, 0.1 "g/ml or 1.5 flg/ml CB applied directly to the arterial wall with a Cordis Microporous Infusion Catheter (MIC). Pigs were sacrificed 3 weeks post-surgery and the left coronary artery was processed for histopathology. Histologically, traumatized and treated coronary arteries in all groups were characterized by tears in the internal elastic lamina which occasionally extended into the tunica media, reorientation of the inner myofibers of the tunica media perpendicular to the lumen, occasional dissecting aneurysms, and intimal hyperplasia. Morphometric evaluation of vascular lumenal area demonstrated a significant difference between treatment groups and the saline control. Saline control pigs had a mean lumenal area of 55.8% (44.2% stenosis) compared to the mean of the proximal and distal vessel lumen areas. Pigs treated with 0.1 flg/ml CB had lumenal areas of 92.1 % (7.9% stenosis, p < 0.01). and pigs treated with 1.5 flg/ml CB had lumenal areas of 112.4% (12.4% dilation, p = 0.001). Treatment with 0.1 flg/ml CB markedly inhibited restenosis and treatment with 1.5 flg/ml CB actually resulted in increased in lumenal area.
Conclusions: rPEG Hirudin administered early and in doses sufficient
In this model of vascular injury, treatment with CB resulted in increased
